GlassScriptPhysician profile
Mohammed Al Areef
NPI 1285156968
$2,458.68
in general payments reported to CMS, 2019-2025
16 companies · $1,882 in 2025
The $1,882 reported for 2025 was more than what 79% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $216 · 2020: $16.93 · 2021: $68.54 · 2022: $77.80 · 2023: $142 · 2024: $56.58 · 2025: $1,882.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,376 · Food and Beverage: $704.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,375.63 |
| Food and Beverage | $704.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,787.79 | 2025 | |
| Boston Scientific Corporation | $196.51 | 2019-2025 | Watchman Flx, Lithovue, Watchman Access System |
| Astellas Pharma US INC | $83.49 | 2019-2023 | Myrbetriq |
| Abbvie INC. | $68.48 | 2025 | |
| Axonics, INC. | $57.02 | 2023 | Axonics, Bulkamid |
| Myriad Genetic Laboratories, INC. | $45.26 | 2021 | |
| Myovant Sciences INC. | $37.95 | 2022 | |
| 180 Medical, INC. | $28.45 | 2019 | |
| Blue Earth Diagnostics | $23.28 | 2021 | |
| Janssen Biotech, INC. | $20.58 | 2022 | |
| Sumitomo Pharma America, INC. | $20.04 | 2024 | Gemtesa |
| Olympus America INC. | $18.77 | 2024 | Bovie, Hd Camera Head, Soltive |
| Ferring Pharmaceuticals INC. | $18.64 | 2019 | |
| Teleflex LLC | $17.77 | 2024 | Urolift |
| Smith+Nephew, INC. | $17.72 | 2023 | Pico, Renasys Go V2 Home |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $16.93 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammed Al Areef listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.